Manon Fiorotto made an impactful UFC headliner debut with a dominant performance against Erin Blanchfield in what could be viewed as a title eliminator match at UFC Atlantic City. She appeared very comfortable in the spotlight.
Apart from Blanchfield’s early guillotine attempt, the fight was all about Fiorotto, who secured a unanimous decision victory over her opponent in over 20 minutes of action. Fiorotto showcased impressive wrestling skills and solid defense against takedowns, while Blanchfield had some moments standing up but couldn’t match the prowess of the 34-year-old. With a perfect 7-0 record in the Octagon, Fiorotto seems poised for a title shot. Secure your tickets for just £125.
This loss marked Blanchfield’s first defeat in the Octagon and her second overall as a professional fighter.
Check out how fellow UFC fighters reacted to Fiorotto’s victory over Blanchfield in the main event as UFC makes its return to Atlantic City to close out the show.
Fiorot’s significant win. Demonstrating the patient and strategic approach that is expected from her – effectively using Counter Strikes and controlling the range.
While Blanchfield had some moments late in the fight, they were ultimately insufficient.
Fioroto currently stands as the top contender #UFCAtlanticCity
— Megan Anderson (@MeganAnderson) March 31, 2024
When your corner seems lost for words during a fight, it’s definitely not a good sign. #UFCAtlanticCity
— Will Brooks (@ILLxWillBrooks) March 31, 2024
Grasso and Shevchenko are likely to outclass both these fighters. Regrettably, neither seems to pose a significant challenge. #UFCAtlanticCity
— Damien Brown (@beatdown155) March 31, 2024
Blanchfield should focus on setting up combinations when closing the distance on Fiorot, or commit to aggressive attacks, understanding that she needs to land multiple strikes to overpower Manon and get closer #UFCAtlanticCity
— Megan Anderson (@MeganAnderson) March 31, 2024
There’s a unique intensity in a women’s main event fight.
— Paulo Costa (Borrachinha) (@BorrachinhaMMA) March 31, 2024
